Zusammenfassung
Unterteilung. Die menschlichen Atemwege werden funktionell in leitende und gasaustauschende Atemwege (Alveolen) eingeteilt. Die leitenden Luftwege warden anatomisch in Nase und/oder Mund, Pharynx, Larynx und Tracheobronchialbaum unterteilt. Dieses komplizierte, verästelte Röhrensystem kann auf verschiedene Art und Weise weiter unterteilt werden (Abb. 97). Wichtig ist, sich nicht auf einen einzigen Teil des Systems zu konzentrieren, sondern die Luftwege als Einheit von der Nase bis zu den Alveolen zu betrachten. Die Form des Lumens sagt etwas über die spezialisierte Aufgabe des jeweiligen Teils der Luftwege aus, und der Charakter des Wandaufbaus ist für Atemwegsobstruktion und -erkrankung von Bedeutung (Abb. 98).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aas K (1972) The biochemical and immunological basis of bronchial asthma. Charles C Thomas, Springfield, pp 1–238
Al Bazzaz F, Grillo H, Kazemi H (1975) Response to exercise in upper airway obstruction. Am Rev Respir Dis 111: 631–40
Azarnoff DL (ed)(1975) Symposium on steroid therapy. WB Saunders, Philadelphia, pp 1–340
Baxter JD, Forsham PH (1972) Tissue effects of glucocorticoids. Am J Med 53: 573–7
Bernstein IL, Siegel SC, Brandon ML et al. (1972) A controlled study of cromolyn sodium sponsored by the Drug Committee of the American Academy of Allergy. J Allergy Clin Immunol 50: 235–45
Bernstein IL (1981) Cromolyn sodium in the treatment of asthma: changing concepts. J Allergy Clin Immunol 68: 247 - 53
Bernstein IL (1983) Asthma in adults: diagnosis and treatment. In: Middleton Jr E, Reed CE, Ellis EF (eds) Allergy: principles and practice, 2nd ed. CVMosby, Saint Louis, pp 901–34
Blackwell G, Carnuccio R, Dirosa M, Flower RJ, Parente L, Percio P (1980) Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature 287: 147–9
Booij-Noord H, Orie NGM, De Vries K (1971) Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone. J Allergy Clin Immunol 48: 344–8
Borum P, Mygind N (1980) Inhibition of the immediate allergic reaction in the nose by the beta2 adreno-stimulant, fenoterol. J Allergy Clin Immunol 66: 25–32
Britton MG, Collins JV, Brown D, Fairhurst NPA, Lambert RG (1976) High-dose corticosteroids in severe acute asthma. Br J Med 2: 73–4
Bürge PS (1982) The effects of corticosteroids on immediate asthmatic reaction. Eur J Respir Dis 63 (suppl 122): 163–6
Clark TJH (1977) Corticosteroids. In: ClarkTJH, Godfrey S Asthma. Chapman and Hall, London, pp 286–302
Clark TJH, Mygind N, Selros O (eds) (1982) International symposium on corticosteroid treatment in allergic airway diseases. Eur J Respir Dis 63 (Suppl 122): 1–278
Dunnill MS (1978) The pathology of asthma. In: Middleton Jr E, Reed CE, Ellis EF (eds) Allergy: principles and practice. CVMosby, Saint Louis, pp 678–86
Ellis EF (1978) Theophylline and derivates. In: Middleton Jr E, Reed CE, Ellis EF (eds) Allergy: principles and practice. CVMosby, Saint Louis, pp 434–453
Ellul-Michalef R (1982) The acute effects of corticosteroids in bronchial asthma. Eur J Respir Dis 63 (Suppl 122): 118–25
Gallager JT, Kent PW, Passatore M, Phipps RJ, Richardson PS (1975) The composition of tracheal mucus, and the nervous control of its secretion in the cat. Proc R Soc R 192: 46–76
Gold WM (1973) Cholinergic pharmacology in asthma. In: Austen KF, Lichtenstein LM (eds) Asthma: physiology, immunopharmacology, and treatment. Academic Press, New York, pp 169–84
Grieco MH (1972) Double blind crossover study of cromolyn sodium inhibition of aerosol antigen. Chest 61: 432–8
Griffin MP, MacDonald N, McFadden ER (1983) Short- and long-term effects of cromolyn sodium on the airway reactivity of asthmatics. J Allergy Clin Immunol 71: 331–8
Groth S, Dirksen H, Mygind N (1984) Intranasal fenoterol in asthmatics: an alternative route of administration. J Allergy Clin Immunol 74: 536–9
Hartley JPR, Charles TJ, Seaton A (1977) Betamethasone valerate inhalation and exerciseinduced asthma. Br J Dis Chest 71: 253–8
Hendeles L, Weinberger M, Wyatt R (1978) Guide to oral theophylline therapy for the treatment of chronic asthma. Am J Dis Child 132: 876–80
Hetzel MR, Clark RJH (1976) Comparison of intravenous and aerosol salbutamol. Br Med J 2: 919
Hirata F, Schiffman E,Venkata Subramanian K, Salomon D, Axelrod J (1980)Aphospholipase
A2 inhibitory protein in rabbit neutrophils induced by glucorticoids. Proc Natl Acad Sci USA 77: 2533–6
Hofbrand BI (ed) (1975) The place of parasympatholytic drugs in the management of chronic obstructive airway diseases. Postgrad Med J 51 (Suppl 7): 1–161
Hogg JC, Pare PD, Boucher R, Michoud M-C, Guerzon G, Moroz L (1977) Pathologic abnormalities in asthma. In: Lichtenstein LM, Austen FK (eds) Asthma: physiology, immunopharmacology and treatment. Academic Press, New York, pp 1–19
Holzman MJ, Sheller JR, Dimeo M, Nadel JA, Boushey HA. (1980) Effect of ganglionic blockade on bronchial reactivity in atopic subjects. Am Rev Respir Dis 122: 17–25
Honsinger RW, Silverstein D, Van Arsdal PP (1972) The eosinophil and allergy: Why? J Allergy Clin Immunol 49: 142–8
Jenne JW (1975) Rationale for methylxanthines in asthma. In: Stein M (ed) New directions in asthma. American College of Chest Physicians, Park Ridge, 111., pp 391–413
Kay AB, Lee TH (1983) Mediators of hypersensitivity in exercise-induced asthma. Eur J Respir Dis 64 (Suppl 128): 237–41
Laursen LC, Weeke B (1983) Enprofylline - effects of a new xanthine derivative in asthmatic patients. Allergy 38: 75–9
Lieberman P, Patterson R, Kunske R (1972) Complications of long-term steroid therapy for asthma. J Allergy Clin Immunol 49: 329–36
Lightbody IM, Ingram CG, Legge JS, Johnson RN (1978) Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitis. Br J Dis Chest 72: 181–6
McAllen M (1970) Long term side effects of corticosteroids. Respiration 27 (Suppl): 250–9
McCarthy D, Milic-Emili J (1973) Closing volume in asymptomatic asthma. Am Rev Respr Dis 107: 559–70
Mossberg B, Strandberg K, Camner P (1977) Stimulatory effect of beta-adrenergic drugs on mucociliary transport. Scand J Respir Dis suppl 101: 71–8
Mygind N, Wihl J-A (1977) Scanning electron microscopy of a bacterial infection of the human nose. Br J Dis Chest 71: 259–67
Mygind N, Clark TJH (eds) (1980) Topical steroid treatment for asthma and rhinitis. Bailliere Tindall, London, pp 1–188
Nadel JA (1973) Neurophysiologic aspects of asthma. In: Austen KF, Lichtenstein LM (eds) Asthma: physiology, immunopharmacology, and treatment. Academic Press, New York, pp 29–38
Netter FH (1979) Respiratory system. The CIBA Collection of Medical Illustrations, volume 7. CIBA Pharmaceutical, New Jersey, pp 1–328
Pakes GE, Brogden RN, Heel RC, Speight TM, Avery GS (1980) Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis. Drugs 20: 237–66
Pepys J, Hutchroft BJ (1975) Bronchial provocation tests in etiologic diagnosis and analysis of asthma. Am Rev Respir Dis 112: 928–59
Preliminary Report of the Brompton Hospital/Medical Research Council Collaborative Trial (1974) Double-blind trial comparing two dosage schedules of beclomethasone dipropionate in the treatment of chronic bronchial asthma. Lancet 2: 303–7
Schatz M (1984) Asthma and pregnancy. In: Dawson A, Simon RA (eds) The practical management of asthma. Gruñe & Stratton, Orlando, pp 195–211
Sheppard D, Nadel JA, Boushey HA (1981) Inhibition of sulfur dioxyde-induced bronchoconstriction by disodium cromoglycate in asthmatic subjects. Am Rev Respir Dis 124: 257–9
Sleigh MA (1977) The nature and action of respiratory tract cilia. In: Brain JD, Proctor DF, Reid LM (eds) Respiratory defense mechanisms, part I. Marcel Dekker, New York, p 247–88
Smyllie HC, Conolly CK (1968) Incidence of serious complications of corticosteroid therapy in respiratory disease. Thorax 23: 571–81
Svedmyr K (1981) Beta2-adrenoceptor stimulants and theophylline in asthma therapy. Eur J Respir Dis 62 (Suppl 116): 1–48
Svedmyr N (1982) Pharmacological effects of glucorticosteroids in the airways. Eur J Respir 63 (Suppl 122): 48–53
Svedmyr N (1983) Methylxanthines in asthma. Agents Actions, (Suppl 13 ): 83–103
Svedmyr N (1983) Airway hyperreactivity: clinical treatment with drugs. In: Simonsson BG (ed) Airway hyperreactivity. Eur J Respir Dis 64 (Suppl 131 ): 313–29
Svedmyr N (1984) Is beta-adrenoceptor sensitivity a limiting factor in asthma therapy? In: Morley J (ed) Beta-adrenoceptors in asthma. Academic Press, London, pp 181–99
Svedmyr N (1985) Intravenous sympathomimetic drugs in acute asthma. In: Weiss EB, Segal MS, Stein M (eds) Status asthmaticus, 2nd ed. University Park Press, Baltimore, chapter 55
Svedmyr N, Simonsson BG (1978) Drugs in the treatment of asthma. PharmacolTher B 3: 397–440
Thiringer G, Svedmyr N (1970) A comparison of the effects of isoprenaline and salbutamol on different beta-receptors in asthmatic patients. Postgrad Med J, ( Suppl 47 ): 44–6
Thiringer G, Svedmyr N (1976) Comparison of infused and inhaled terbutaline in patients with asthma. Scand J Respir Dis 57: 17–24
Thompson P, Friedman M (1977) Intramuscular salbutamol in treatment of acute exacerbations of childhood asthma. Arch Dis Child 52: 551–4
Vale JR, Molgaard F (eds) (1983) Fenoterol inhalation powder. Eur J Respir Dis 64 (Suppl 130): 1–72
Venter JC, Fraser CM, Nelson HS, Middleton Jr E (1983) Adrenergic agents. In: Middleton Jr E, Reed CE, Ellis EF (eds) Allergy: principles and practice, 2nd ed. CVMosby, Saint Louis, pp 503–33
Weinberger M (1984) The pharmacology and therapeutic use of theophylline. J Allergy Clin Immunol 73: 525–44
Widdicombe J, Davies A (1983) Respiratory physiology. Edward Arnold, London, pp 1–118
Woodcock AA, Johnson MAA, Geddes DM (1983) Theophylline prescribing, serum concentrations, and toxocity. Lancet 2: 610–3
Woolcock A J (1977) Inhaled drugs in the prevention of asthma. Am Rev Respir Dis 115:191–4
Zanjanian MH (1980) Expectorants and antitussive agents: are they helpful? Ann Allergy 44: 290–5
Ziment I (1978) Respiratory pharmacology and therapeutics. WB Saunders
Rights and permissions
Copyright information
© 1989 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt
About this chapter
Cite this chapter
Mygind, N. (1989). Asthma. In: Grundriß der Allergologie. Steinkopff. https://doi.org/10.1007/978-3-642-72426-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-72426-8_5
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-0764-7
Online ISBN: 978-3-642-72426-8
eBook Packages: Springer Book Archive